Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07605702
What this trial is testing

The Canopy Cancer Collective Clinical Registry Protocol

Who this might be right for
Gastrointestinal NeoplasmsPancreatic CancerColorectal Cancer+4 more
Canopy Cancer Collective, LLC 100,000
Testing effectiveness (Phase 2)UnknownNCT03221400
What this trial is testing

PEN-866 in Patients With Advanced Solid Malignancies

Who this might be right for
CarcinomaEndometrial AdenocarcinomaNeoplasms+16 more
Tarveda Therapeutics 340
Early research (Phase 1)Study completedNCT04943900
What this trial is testing

BMS-986416 With and Without Nivolumab in Select Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 67
Early research (Phase 1)Study completedNCT05546853
What this trial is testing

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Hospital, Grenoble 43
Not applicableNot Yet RecruitingNCT05895214
What this trial is testing

Mesopancreas Study in Pancreatic Cancer

Who this might be right for
PDACPancreatoduodenectomyMargin, Resection+2 more
Heinrich-Heine University, Duesseldorf 500
Early research (Phase 1)Active Not RecruitingNCT05607953
What this trial is testing

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
TriSalus Life Sciences, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Not applicableActive Not RecruitingNCT02757859
What this trial is testing

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 845
Not applicableStudy completedNCT01155882
What this trial is testing

Registry Study - Whipple at the Splenic Artery

Who this might be right for
Pancreas Cancer
Washington University School of Medicine 13
Not applicableStudy completedNCT02150746
What this trial is testing

Circulating Tumor Cells in Operative Blood

Who this might be right for
Carcinoma, Pancreatic Ductal
University of Florida 3
Testing effectiveness (Phase 2)Looking for participantsNCT07483983
What this trial is testing

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Who this might be right for
Metastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris 60
Not applicableLooking for participantsNCT07587866
What this trial is testing

Panuri Performance Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A 1,100
Testing effectiveness (Phase 2)UnknownNCT05042128
What this trial is testing

The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 158
Testing effectiveness (Phase 2)Looking for participantsNCT07303465
What this trial is testing

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
KRAS G12D MutationsPancreatic Ductal Adenocarcinoma (PDAC)
Ranok Therapeutics (Hangzhou) Co., Ltd. 60
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01547260
What this trial is testing

Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma MetastaticPancreatic Ductal Adenocarcinoma
Maria Liljefors 34
Not applicableLooking for participantsNCT05630989
What this trial is testing

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, MD 80
Testing effectiveness (Phase 2)Looking for participantsNCT06503146
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Who this might be right for
SarcomaSmall Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)Mesothelioma+7 more
National Cancer Institute (NCI) 320
Not applicableTemporarily pausedNCT04700488
What this trial is testing

Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Cedars-Sinai Medical Center 36
Early research (Phase 1)Not Yet RecruitingNCT06913218
What this trial is testing

MRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Who this might be right for
Pancreas CancerPancreas Cancer, Duct Cell Adenocarcinoma
Akeso 60
Next Page